Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways
Authors
Keywords
TGFBR2, Hypoxia, EZH2, MicroRNA-93, Prostate cancer
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-27
DOI
10.1186/s13046-018-0764-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An androgen-regulated miR-2909 modulates TGFβ signalling through AR/miR-2909 axis in prostate cancer
- (2017) Shiekh Gazalla Ayub et al. GENE
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond
- (2017) Mary Nakazawa et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
- (2017) Min-Zu Wu et al. NATURE CELL BIOLOGY
- The Potential of MicroRNAs as Prostate Cancer Biomarkers
- (2016) Linda Fabris et al. EUROPEAN UROLOGY
- miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
- (2016) R. Rupaimoole et al. Cancer Discovery
- The HIF/PHF8/AR axis promotes prostate cancer progression
- (2016) D Tong et al. Oncogenesis
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
- (2015) S. Gillessen et al. ANNALS OF ONCOLOGY
- Suppressing TGF Signaling in Regenerating Epithelia in an Inflammatory Microenvironment Is Sufficient to Cause Invasive Intestinal Cancer
- (2015) H. Oshima et al. CANCER RESEARCH
- Genomic Predictors of Outcome in Prostate Cancer
- (2015) Peter J. Boström et al. EUROPEAN UROLOGY
- Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options
- (2015) Benjamin A. Gartrell et al. EUROPEAN UROLOGY
- Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2
- (2015) Noel F.C.C. de Miranda et al. GASTROENTEROLOGY
- EZH2 Modulates Angiogenesis In Vitro and in a Mouse Model of Limb Ischemia
- (2015) Tijana Mitić et al. MOLECULAR THERAPY
- Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis
- (2015) X Meng et al. ONCOGENE
- Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer
- (2015) Yan Li et al. Scientific Reports
- MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer
- (2014) Wenpeng Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells
- (2014) Maximilian Marhold et al. MOLECULAR CANCER RESEARCH
- Prostate Cancer Induced by Loss of Apc Is Restrained by TGFβ Signaling
- (2014) Glen A. Bjerke et al. PLoS One
- The effects of nonspecific HIF1αinhibitors on development of castrate resistance and metastases in prostate cancer
- (2014) Weranja K. B. Ranasinghe et al. Cancer Medicine
- Hypoxia-regulated microRNAs in human cancer
- (2013) Guomin Shen et al. ACTA PHARMACOLOGICA SINICA
- EpCAM expression in the prostate cancer makes the difference in the response to growth factors
- (2013) Go J. Yoshida et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer
- (2013) S Mishra et al. ONCOGENE
- A reciprocal role of prostate cancer on stromal DNA damage
- (2013) J Banerjee et al. ONCOGENE
- Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif
- (2013) Mark P. Hamilton et al. Nature Communications
- Molecular Classification of Prostate Cancer Progression: Foundation for Marker-Driven Treatment of Prostate Cancer
- (2013) C. J. Logothetis et al. Cancer Discovery
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
- (2010) Paul Cao et al. Molecular Cancer
- Methylation Silencing of Transforming Growth Factor- Receptor Type II in Rat Prostate Cancers
- (2008) S. Yamashita et al. CANCER RESEARCH
- Stromal Transforming Growth Factor- Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity
- (2008) V. R. Placencio et al. CANCER RESEARCH
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
- (2008) Roy Vergis et al. LANCET ONCOLOGY
- Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
- (2008) X Li et al. ONCOGENE
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started